XIth Eurasian Hematology-Oncology Congress - EHOC 2020

 

XIth Eurasian Hematology-Oncology Congress - EHOC 2020
P

Efficacy Evidence on Therapeutic Vaccine in Oncology: What Are the Conditions of Use? Does Association to Chemotherapy Impair Vaccine Efficiency? What Is the Adjuvant Essential for?

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Patrick Frayssinet
By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Patrick Frayssinet
12 views
January 12, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Basic Science
22:24

Cancer Stem Cells: How Do We Get to Heterogeneous Cancers? Do We Nee…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

R. Gale

15 views
19:41

Exosomes in Hematological Malignancies and Pre-Cancerous States: Can…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

R. Kusec

7 views
24:01

Efficacy Evidence on Therapeutic Vaccine in Oncology: What Are the C…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

P. Frayssinet

12 views